Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
University of California, San Francisco
University of California, San Francisco
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Jazz Pharmaceuticals
Bayer
Hoffmann-La Roche
National Institutes of Health Clinical Center (CC)
Psyence Australia Pty Ltd
Daiichi Sankyo
OHSU Knight Cancer Institute
Mayo Clinic
Merck Sharp & Dohme LLC
Tempus AI
Elevation Oncology
Rain Oncology Inc
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Exelixis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Universitair Ziekenhuis Brussel
Charite University, Berlin, Germany
pharmaand GmbH
Hoffmann-La Roche
Northwestern University
Istituto Clinico Humanitas
Main Line Health
Cambridge University Hospitals NHS Foundation Trust
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
Wake Forest University Health Sciences
Roswell Park Cancer Institute
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Northwestern University